Anshan Hifichem Co., Ltd. (SHE:300758)
China · Delayed Price · Currency is CNY 14.50
+0.57 (4.09%)
May 21, 2026, 3:05 PM CST
Anshan Hifichem Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,513 | 1,478 | 1,543 | 1,198 | 1,159 | 1,319 |
Other Revenue | 17.49 | 17.49 | 24.71 | 20.28 | 49.47 | 27.56 |
| 1,531 | 1,495 | 1,568 | 1,218 | 1,209 | 1,347 | |
Revenue Growth (YoY) | -4.94% | -4.64% | 28.75% | 0.77% | -10.27% | 33.58% |
Cost of Revenue | 1,079 | 1,040 | 1,072 | 910.31 | 908.81 | 921.26 |
Gross Profit | 451.95 | 454.8 | 495.62 | 307.51 | 299.75 | 425.64 |
Selling, General & Admin | 219.56 | 213.96 | 202.71 | 180.5 | 189.91 | 137.62 |
Research & Development | 92.03 | 100.03 | 96.26 | 81.25 | 90.97 | 81.73 |
Other Operating Expenses | 9.94 | 8.32 | 8.37 | 9.21 | 11.41 | 10.8 |
Operating Expenses | 323.45 | 323.59 | 308.13 | 271.9 | 294.27 | 229.87 |
Operating Income | 128.5 | 131.21 | 187.49 | 35.61 | 5.47 | 195.77 |
Interest Expense | -45.9 | -45.99 | -38.67 | -35.9 | -29.88 | -15.92 |
Interest & Investment Income | 5.79 | 10.02 | 19.11 | 8.92 | 10.1 | 7.83 |
Currency Exchange Gain (Loss) | -2.51 | -2.51 | -1.57 | -0.12 | 8.18 | -2.42 |
Other Non Operating Income (Expenses) | -2.9 | -0.36 | 3.99 | -5.25 | -1.02 | 0.56 |
EBT Excluding Unusual Items | 82.98 | 92.36 | 170.35 | 3.26 | -7.14 | 185.82 |
Impairment of Goodwill | -3.92 | -3.92 | -6.34 | - | - | - |
Gain (Loss) on Sale of Investments | -12.88 | -13.25 | -12.33 | 2.13 | 2.99 | 13.35 |
Gain (Loss) on Sale of Assets | -0.16 | -0.07 | 0.16 | 0.32 | 0.05 | 5.02 |
Asset Writedown | -18.57 | -11.91 | -10 | -0.97 | -2.84 | -4.38 |
Legal Settlements | -0.75 | -0.75 | -0.91 | -1.88 | - | - |
Other Unusual Items | 0.24 | 0.58 | 6.29 | 5.27 | 3.41 | 8.33 |
Pretax Income | 46.94 | 63.04 | 147.22 | 8.13 | -3.54 | 220.92 |
Income Tax Expense | -0.48 | 0.88 | 15.68 | -8.96 | -14.83 | 20.68 |
Earnings From Continuing Operations | 47.42 | 62.16 | 131.54 | 17.09 | 11.29 | 200.24 |
Minority Interest in Earnings | -1.24 | -1 | -6.61 | -6.09 | -14.09 | -20.27 |
Net Income | 46.18 | 61.16 | 124.93 | 11 | -2.79 | 179.97 |
Net Income to Common | 46.18 | 61.16 | 124.93 | 11 | -2.79 | 179.97 |
Net Income Growth | -65.57% | -51.05% | 1035.48% | - | - | 2.57% |
Shares Outstanding (Basic) | 410 | 408 | 403 | 367 | 279 | 391 |
Shares Outstanding (Diluted) | 410 | 408 | 403 | 367 | 279 | 391 |
Shares Change (YoY) | 4.88% | 1.17% | 9.88% | 31.26% | -28.59% | 20.41% |
EPS (Basic) | 0.11 | 0.15 | 0.31 | 0.03 | -0.01 | 0.46 |
EPS (Diluted) | 0.11 | 0.15 | 0.31 | 0.03 | -0.01 | 0.46 |
EPS Growth | -67.17% | -51.61% | 933.33% | - | - | -14.82% |
Free Cash Flow | -40.33 | -98.26 | 57.58 | -163.59 | -99.43 | -0.63 |
Free Cash Flow Per Share | -0.10 | -0.24 | 0.14 | -0.45 | -0.36 | -0.00 |
Dividend Per Share | 0.075 | 0.075 | 0.050 | - | - | 0.700 |
Dividend Growth | 50.00% | 50.00% | - | - | - | - |
Gross Margin | 29.52% | 30.42% | 31.61% | 25.25% | 24.80% | 31.60% |
Operating Margin | 8.39% | 8.77% | 11.96% | 2.92% | 0.45% | 14.54% |
Profit Margin | 3.02% | 4.09% | 7.97% | 0.90% | -0.23% | 13.36% |
Free Cash Flow Margin | -2.63% | -6.57% | 3.67% | -13.43% | -8.23% | -0.05% |
EBITDA | 273.85 | 276.74 | 333.73 | 172.63 | 126.35 | 279.56 |
EBITDA Margin | 17.89% | 18.51% | 21.28% | 14.18% | 10.46% | 20.76% |
D&A For EBITDA | 145.35 | 145.53 | 146.24 | 137.03 | 120.88 | 83.79 |
EBIT | 128.5 | 131.21 | 187.49 | 35.61 | 5.47 | 195.77 |
EBIT Margin | 8.39% | 8.77% | 11.96% | 2.92% | 0.45% | 14.54% |
Effective Tax Rate | - | 1.40% | 10.65% | - | - | 9.36% |
Revenue as Reported | 1,531 | 1,495 | 1,568 | 1,218 | 1,209 | 1,347 |
Advertising Expenses | - | 3.6 | 2.55 | 1.55 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.